- Benchmark ASINB0GY2VLGKN
- MarketplaceUS
- Category ID3763391
- Analyzed Products
- Keywordhealth care products
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥35.05estimated
- Data Date2026-07-30
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，已经是明显的价格战/低差异化市场。 现有样本里可判定的新释放产品盈利率是0%，新品牌也是0个；新上架样本2个全部亏损，且没有任何真正可复制的“小品牌成功案例”。
证据很直接： 市场里只有2个老品牌样本，分别是 Cardinal Health 和 Battewa；这2个品牌的新产品都不赚钱。Battewa 的新款 B0GY2VLGKN 售价 58.41 美元，月销约 50 件，月营收约 2,920.50 美元，47 条评论、评分 4.1，前期投入约 5,517.99 美元，但仍然亏损；Cardinal Health 的 B0FWM8S7KK 和 B017A814TK、B0D1D82LTZ 也都不盈利。失败原因反复出现“缺乏独特性”“市场太小或竞争极端”“好但利润低”，说明不是单靠预算就能赢，而是同质化严重、利润被压得很薄。用户 50 万人民币预算虽然能覆盖单个 ASIN 的前期启动，但在这里主要只能买到试错空间，不能买到确定性回报。
对两类入场者都不友好： 大品牌如果没有明显的功能升级、设计差异或渠道优势，进来后也很容易被低利润拖死；小品牌更没有合格的成功案例可参考，而且样本里已经看不到 <300 评论的真实成功路径，反而更像需要激进投放和促销去硬抢流量。结论很明确：不要进入。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing这不是适合进入的市场：利润率和新入场成功率都接近为零，且整体呈现价格战/低效竞争特征。 你的预算 50万人民币本身足以覆盖单个 ASIN 的前期启动，但在这个市场里，钱不是主要问题，问题是几乎没有可复制的盈利样本，贸然进入大概率会把预算消耗在试错上。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?100.00%New listing success rate (old brands):0.00%Alternatives- 一次性失禁内裤/成人纸尿裤：通常单次成本更低、购买更容易，适合临时或旅行场景，不需要反复清洗；对于还在试水需求的用户，这是最直接的替代方案。
- 可水洗尿垫/床垫保护垫：比失禁内裤更便宜，铺在座椅、床上或车上即可用，适合夜间、居家或长时间坐卧时减少漏尿风险。
- 护理垫/一次性吸收垫：价格通常较低，使用门槛低，可贴身内裤外或放在椅垫上，适合轻度漏尿、产后护理或短时外出。
- 高吸收卫生巾/产后垫：对轻度尿渗漏人群是更便宜且更容易买到的替代，尤其适合白天活动量不大、漏量较轻的情况。
- 外穿防水保护裤/可重复使用护套：更像“外层防护”，可与普通内裤搭配使用，减少购买专用失禁内裤的必要，适合已经有常规内裤库存的用户。
- 盆底肌训练资源（如凯格尔训练App/纸质训练计划）：对轻度、可改善型漏尿用户是低成本替代，尤其适合不想立即购买护理用品的人群。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，结论很明确：它已经是高风险、接近价格战的市场。 现有样本里可判定的盈利产品比例是0%，新上架产品盈利率也是0%；而且已出现老品牌持续推新但依然不赚钱的情况，说明不是“努力就能赢”，而是同质化严重、利润被压得很薄。
证据也很直接：Battewa 这个老品牌只有 2 个可见产品，盈利率 0%，其中新款 B0GY2VLGKN 依然不盈利，月销约 50 件、月营收约 2,920.50 美元、售价 58.41 美元、47 条评论、评分 4.1，早期投入约 5,517.99 美元（其中广告约 1,256.45 美元），说明要把货跑起来并不轻松，但即使跑起来也未能形成健康利润。 另一类老品牌样本 Cardinal Health 的新款 B0FWM8S7KK、B0D1D82LTZ 也都是不盈利，说明这个赛道里“老品牌 + 新品”同样难赚钱；更关键的是，产品失败原因反复出现“缺乏独特性”“市场太小或竞争极端”“好但利润低”，这就是典型的高同质化市场。用户预算 50 万元人民币虽然足以覆盖单个 ASIN 的前期启动，但在这里并不能换来确定性回报，反而更像是在高竞争里买入门票。
如果硬要找可模仿的对象，只有失败样本可参考，而不是成功样本。 大品牌该盯住的不是“成功模板”，而是如何避开 Cardinal Health 的标准化一次性护理内裤路线，以及 Battewa 这种“常规版型 + 基础功能组合 + 认证卖点”仍然卖不出利润的路径。小品牌这边没有真正合格的成功案例（<300 评论且可证明盈利的样本缺失），这本身就是危险信号：市场并不欢迎轻量进入者，若要竞争，很可能需要更激进的投放和促销方式，甚至接近“掠夺式营销”。短结论：不要进。
Old brand with the most profitable new productsBattewa
Recent Monthly Revenue (USD):-(-)B0F99MWNP6Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$2,920.50(50pcs/month)B0GY2VLGKN (4.1/5 (47 Reviews))Brand is an old entry in this marketNew Upgraded Version on Old ASINInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 与常规白色护理内裤相比，彩色多配色外观更醒目，缩略图点击率更高。
- |
- 普通内裤式版型，适合想要日常穿搭感、低尴尬感的女性用户。
- |
- 可水洗、除味、防漏，兼顾功能和日常使用场景。
B0GY2VLGKN (4.1/5 (47 Reviews))Brand is an old entry in this marketNew Upgraded Version on Old ASINInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- 与可洗款内裤型产品差异最大，是箱装一次性护理内裤，形态最不同。
- |
- 白色医护耗材风格明显，适合机构采购或家庭囤货场景。
- |
- 最大吸收量、即弃便捷，满足高频护理需求，购买决策清晰。
B0FWM8S7KKBrand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：新品牌成功率为0%，新上架产品盈利率也为0%，而且市场已经被老牌玩家占住。 现有数据里没有看到真正可复制的小品牌成功案例，反而是低差异化、低利润、强竞争的典型价格战市场；以你50万人民币的预算，最多只能勉强启动，远不足以支撑长期品牌、研发和合规投入。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0GY2VLGKNBattewa2026-05-07No$58.4150pcs$2920.540.29%$1176.67B0D1D82LTZCardinal Health2024-04-10No$67.92-pcs$--1.68%$-
B017A814TKCardinal Health2018-03-30No$58.57-pcs$--16.41%$-B0F99MWNP6Battewa2025-05-20No$--pcs$--%$-B0FWM8S7KKCardinal Health2025-10-16No$--pcs$--%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0GY2VLGKNBattewa2026-05-07No$58.4150pcs$2920.540.29%$1176.67B0FWM8S7KKCardinal Health2025-10-16No$--pcs$--%$-#New Product Success Rates
Listing这个市场不值得进入，已经是高竞争、低成功率、接近价格战的市场。 当前样本里可识别的可盈利产品占比为0%，新上架产品盈利率也是0%；而且本次抓到的两个新上架样本全部亏损，说明新人几乎没有真实突围空间。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Cardinal HealthBattewa#Success Rate by Entry Time
Listing结论很明确：这个市场不适合进入，属于高风险且已明显失真。 现有数据里只有2个新发布、且全部来自老品牌，盈利率为0%，最近新增也没有形成真正的新品牌机会；这不是一个给新品牌或小卖家准备的市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 1 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 1 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 1 2026/6 0 0 0 0 0 0 0 0 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases